SLC1A3 contributes to L‐asparaginase resistance in solid tumors
Jianhui Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Reuven Agami(The Netherlands Cancer Institute), Natalie Proost(The Netherlands Cancer Institute), Gerrit J. Poelarends(University of Groningen), Olaf van Tellingen(Dutch Cancer Society), Remco Nagel(The Netherlands Cancer Institute), Alejandro P. Ugalde(The Netherlands Cancer Institute), Marieke van de Ven(The Netherlands Cancer Institute), Ruiqi Han(Erasmus MC), Artur M Burylo(The Netherlands Cancer Institute), Celia R. Berkers(Utrecht University), Abhijeet Pataskar(The Netherlands Cancer Institute), Esther A. Zaal(Utrecht University), Ji‐Ying Song(Oncode Institute), Haigen Fu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 74
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
|The EMBO Journal|2007|812